Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients u...
Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience
About this item
Full title
Author / Creator
Al‐Kassou, Baravan , Veulemans, Verena , Shamekhi, Jasmin , Maier, Oliver , Piayda, Kerstin , Zeus, Tobias , Aksoy, Adem , Zietzer, Andreas , Meertens, Max , Mauri, Victor , Weber, Marcel , Sinning, Jan‐Malte , Grube, Eberhard , Adam, Matti , Bakhtiary, Farhad , Zimmer, Sebastian , Baldus, Stephan , Kelm, Malte , Nickenig, Georg and Sedaghat, Alexander
Publisher
United States: Wiley
Journal title
Language
English
Formats
Publication information
Publisher
United States: Wiley
Subjects
More information
Scope and Contents
Contents
Background
Despite major advances, transcatheter aortic valve replacement (TAVR) is still associated with procedure‐specific complications. Although previous studies reported lower bleeding rates in patients receiving protamine for heparin reversal, the optimal protamine‐to‐heparin dosing ratio is unknown.
Hypothesis
The aim of this study...
Alternative Titles
Full title
Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience
Authors, Artists and Contributors
Author / Creator
Veulemans, Verena
Shamekhi, Jasmin
Maier, Oliver
Piayda, Kerstin
Zeus, Tobias
Aksoy, Adem
Zietzer, Andreas
Meertens, Max
Mauri, Victor
Weber, Marcel
Sinning, Jan‐Malte
Grube, Eberhard
Adam, Matti
Bakhtiary, Farhad
Zimmer, Sebastian
Baldus, Stephan
Kelm, Malte
Nickenig, Georg
Sedaghat, Alexander
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9849438
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9849438
Other Identifiers
ISSN
0160-9289,1932-8737
E-ISSN
1932-8737
DOI
10.1002/clc.23936
